248 related articles for article (PubMed ID: 17855350)
21. The Semaphorin 4D receptor Plexin-B1 is a GTPase activating protein for R-Ras.
Oinuma I; Ishikawa Y; Katoh H; Negishi M
Science; 2004 Aug; 305(5685):862-5. PubMed ID: 15297673
[TBL] [Abstract][Full Text] [Related]
22. Plexin signaling hampers integrin-based adhesion, leading to Rho-kinase independent cell rounding, and inhibiting lamellipodia extension and cell motility.
Barberis D; Artigiani S; Casazza A; Corso S; Giordano S; Love CA; Jones EY; Comoglio PM; Tamagnone L
FASEB J; 2004 Mar; 18(3):592-4. PubMed ID: 14734633
[TBL] [Abstract][Full Text] [Related]
23. Sema4D, the ligand for Plexin B1, suppresses c-Met activation and migration and promotes melanocyte survival and growth.
Soong J; Chen Y; Shustef EM; Scott GA
J Invest Dermatol; 2012 Apr; 132(4):1230-8. PubMed ID: 22189792
[TBL] [Abstract][Full Text] [Related]
24. The semaphorin 4D-plexin-B signalling complex regulates dendritic and axonal complexity in developing neurons via diverse pathways.
Vodrazka P; Korostylev A; Hirschberg A; Swiercz JM; Worzfeld T; Deng S; Fazzari P; Tamagnone L; Offermanns S; Kuner R
Eur J Neurosci; 2009 Oct; 30(7):1193-208. PubMed ID: 19788569
[TBL] [Abstract][Full Text] [Related]
25. Diabetes causes bone marrow endothelial barrier dysfunction by activation of the RhoA-Rho-associated kinase signaling pathway.
Mangialardi G; Katare R; Oikawa A; Meloni M; Reni C; Emanueli C; Madeddu P
Arterioscler Thromb Vasc Biol; 2013 Mar; 33(3):555-64. PubMed ID: 23307872
[TBL] [Abstract][Full Text] [Related]
26. Sema4D/Plexin-B1 promotes the progression of osteosarcoma cells by activating Pyk2-PI3K-AKT pathway.
Li C; Wan L; Wang P; Guan X; Li C; Wang X
J Musculoskelet Neuronal Interact; 2021 Dec; 21(4):577-583. PubMed ID: 34854398
[TBL] [Abstract][Full Text] [Related]
27. Molecular dissection of the semaphorin 4D receptor plexin-B1-stimulated R-Ras GTPase-activating protein activity and neurite remodeling in hippocampal neurons.
Oinuma I; Katoh H; Negishi M
J Neurosci; 2004 Dec; 24(50):11473-80. PubMed ID: 15601954
[TBL] [Abstract][Full Text] [Related]
28. Focal adhesion kinase as a RhoA-activable signaling scaffold mediating Akt activation and cardiomyocyte protection.
Del Re DP; Miyamoto S; Brown JH
J Biol Chem; 2008 Dec; 283(51):35622-9. PubMed ID: 18854312
[TBL] [Abstract][Full Text] [Related]
29. Plexin B1 suppresses c-Met in melanoma: a role for plexin B1 as a tumor-suppressor protein through regulation of c-Met.
Stevens L; McClelland L; Fricke A; Williamson M; Kuo I; Scott G
J Invest Dermatol; 2010 Jun; 130(6):1636-45. PubMed ID: 20164843
[TBL] [Abstract][Full Text] [Related]
30. Optogenetic activation of Plexin-B1 reveals contact repulsion between osteoclasts and osteoblasts.
Deb Roy A; Yin T; Choudhary S; Rodionov V; Pilbeam CC; Wu YI
Nat Commun; 2017 Jun; 8():15831. PubMed ID: 28635959
[TBL] [Abstract][Full Text] [Related]
31. ErbB-2 and met reciprocally regulate cellular signaling via plexin-B1.
Swiercz JM; Worzfeld T; Offermanns S
J Biol Chem; 2008 Jan; 283(4):1893-901. PubMed ID: 18025083
[TBL] [Abstract][Full Text] [Related]
32. Plexin B1 is repressed by oncogenic B-Raf signaling and functions as a tumor suppressor in melanoma cells.
Argast GM; Croy CH; Couts KL; Zhang Z; Litman E; Chan DC; Ahn NG
Oncogene; 2009 Jul; 28(30):2697-709. PubMed ID: 19483722
[TBL] [Abstract][Full Text] [Related]
33. Sema4D induces angiogenesis through Met recruitment by Plexin B1.
Conrotto P; Valdembri D; Corso S; Serini G; Tamagnone L; Comoglio PM; Bussolino F; Giordano S
Blood; 2005 Jun; 105(11):4321-9. PubMed ID: 15632204
[TBL] [Abstract][Full Text] [Related]
34. The semaphorin receptor plexin-B1 specifically interacts with active Rac in a ligand-dependent manner.
Vikis HG; Li W; He Z; Guan KL
Proc Natl Acad Sci U S A; 2000 Nov; 97(23):12457-62. PubMed ID: 11035813
[TBL] [Abstract][Full Text] [Related]
35. Cobalt chloride induces RhoA/ROCK activation and remodeling effect in H9c2 cardiomyoblasts: Involvement of PI3K/Akt and MAPK pathways.
Cheng CI; Lee YH; Chen PH; Lin YC; Chou MH; Kao YH
Cell Signal; 2017 Aug; 36():25-33. PubMed ID: 28435089
[TBL] [Abstract][Full Text] [Related]
36. Anastellin, the angiostatic fibronectin peptide, is a selective inhibitor of lysophospholipid signaling.
Ambesi A; McKeown-Longo PJ
Mol Cancer Res; 2009 Feb; 7(2):255-65. PubMed ID: 19208746
[TBL] [Abstract][Full Text] [Related]
37. Sema4D/plexin-B1 activates GSK-3beta through R-Ras GAP activity, inducing growth cone collapse.
Ito Y; Oinuma I; Katoh H; Kaibuchi K; Negishi M
EMBO Rep; 2006 Jul; 7(7):704-9. PubMed ID: 16799460
[TBL] [Abstract][Full Text] [Related]
38. Semaphorin 4D/Plexin-B1-mediated M-Ras GAP activity regulates actin-based dendrite remodeling through Lamellipodin.
Tasaka G; Negishi M; Oinuma I
J Neurosci; 2012 Jun; 32(24):8293-305. PubMed ID: 22699910
[TBL] [Abstract][Full Text] [Related]
39. Integrin α6β4 cooperates with LPA signaling to stimulate Rac through AKAP-Lbc-mediated RhoA activation.
O'Connor KL; Chen M; Towers LN
Am J Physiol Cell Physiol; 2012 Feb; 302(3):C605-14. PubMed ID: 22049212
[TBL] [Abstract][Full Text] [Related]
40. Phosphatidylinositol-4-phosphate 5-kinase and GEP100/Brag2 protein mediate antiangiogenic signaling by semaphorin 3E-plexin-D1 through Arf6 protein.
Sakurai A; Jian X; Lee CJ; Manavski Y; Chavakis E; Donaldson J; Randazzo PA; Gutkind JS
J Biol Chem; 2011 Sep; 286(39):34335-45. PubMed ID: 21795701
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
